found with islet tumours, but our results suggest that they are raised, particularly the 'atypical' insulin-like activity levels. It must be remembered that insulin secretion is stimulated by a rise in blood sugar, and so one would expect subnormal levels of serum insulin during any hypoglycaemia which did not arise from overproduction of insulin. Pre-operative assays showed at least normal levels of serum insulin in the hypoglycemic fasting samples. Some of our patients' pre-operative glucose tolerance tests were made after shorter (threeor four-hour) fasts to avoid the test starting from hypoglycwmia; and it is interesting to note that there was then less postglucose hypoglycxmia than after a twelve-hour fast. Pre-operatively, little more insulin was released after the glucose load, unlike the postoperative tests or the tests in normal subjectsthis could be because the islets have been under some constant drive. Post-operatively onepatient's glucose tolerance test showed a continuing tendency to hypoglycimia at nine and twelve months, which initially caused us to worry over her recovery; but by eighteen months the glucose tolerance test had returned to normal. This might also suggest hyperplastic islets which cannot easily settle down to quiescence after removal of the tumour, which may have been stimulating them.
Thus, our evidence suggests that the tumour releases a chronic stimulus to the patient's isletswe could not find evidence that it was leucine, though it might be a similar substance released from the tumour. Further studies on these cases may throw further light on the control of normal insulin secretion. Endocrine and Metabolic Consequences of Carcinoma of the Bronchus Undifferentiated cancer cells can, under certain circumstances, synthesize substances which have properties indistinguishable from known hormones. This is a revolutionary idea to those who were brought up in the orthodox belief that hormones were complex chemical substances each synthesized by a highly specialized histological cell type found only in the endocrine glands. This versatility of cancer cells is particularly well exemplified by oat cell carcinoma of the bronchus which can synthesize substances as diverse as corticotrophin, parathormone and antidiuretic hormone. The substances formed may not be chemically identical with the natural polypeptides synthesized by the appropriate endocrine glands, but at least they have biological properties identical with them.
REFERENCE
Bilateral Adrenocortical Hyperplasia Numerically, one important complication of neoplasia is the production of corticotrophin (ACTH) by the tumour. The resultant stimulation of the adrenal cortex gives rise to a very high plasma concentration of cortisol, which is often far higher than is found in true Cushing's syndrome. Despite this, only a minority of patients exhibit the clinical features of Cushing's syndrome, perhaps because they do not live long enough for the physical changes to develop. CEdema of the legs is a common complaint. They may also become diabetic.
The very high rate of secretion of cortisol leads to the development of hypokalhmic alkalosis, with inappropriately large amounts of potassium excreted by the kidneys. So great may be the potassium loss that it may be impossible to correct this with potassium supplements or spironolactone.
So large is the amount of corticotrophin excreted by these tumours that additional stimulation of the adrenal cortex cannot be achieved by the administration of injected corticotrophin. Attempts to suppress the release of endogenous corticotrophin by the administration of large doses of dexamethasone also fail. Hypophysectomy likewise fails to reduce plasma cortisol concentration but operative removal of the tumour or successful irradiation will result in cure of the complication, with recurrence if metastases appear. High concentrations of corticotrophin have been found in both plasma and tumour. This complication is most commonly seen in oat cell carcinoma of the bronchus, thymus, pancreas and ovary but has been found in a wide variety of malignancies.
Hypercalcawmia
Second, perhaps, in frequency to corticotrophin production by tumours is synthesis of parathormone, resulting in hypercalcxmia, hypophosphatemia and hypercalcuria with the attendant clinical features of hypercalcaemia from any cause, namely polyuria, thirst, constipation and mental confusion. Hypercalcaemia frequently occurs in malignant disease as the result of the release of calcium from bone in osteolytic secondaries. In the complication we are discussing bony metastases are absent and the hypercalcxmia results from release by the tumour of a substance indistinguishable in its physiological and immunological properties from parathyroid hormone. Removal or irradiation of the tumour results in a fall of plasma calcium concentration to normal, with a rise if metastases appear.
The neoplasms commonly associated with this tumour are oat cell carcinoma of the bronchus and hypernephroma, but it has also been reported with carcinoma of the ovary, pancreas, uterus, colon and breast.
Dilutional Hyponatramia
Oat cell carcinoma of the bronchus may secrete antidiuretic hormone as a result of which plasma water is increased in volume, with dilution of plasma constituents, particularly noticeable in the plasma sodium concentration, which may be as low as 110 mEq/l. and the blood urea concentration which is commonly about 20 mg/100 ml.
Hyponatremia due to dilution is differentiated from hyponatrwmia due to depletion of sodium, as in Addison's disease, by the absence of hIemoconcentration and of extrarenal uremia. The blood pressure is commonly slightly elevated, rather than low as in Addison's disease. There is, however, an element of sodium depletion in the hyponatremia, since the secretion of aldosterone is decreased in these patients, presumably as the result of the increased plasma volume, so that the amount of sodium lost in the urine is inappropriate in the presence of a low plasma sodium concentration. The continued release of antidiuretic hormone by the tumour is, of course, also unphysiological in the presence of hyponatrwmia and reduced plasma osmolarity and this metabolic complication of cancer has been referred to as 'inappropriate secretion of antidiuretic hormone.
A certain proportion of patients with this complication also exhibit defective proximal renal reabsorption of glucose and amino acids and also of potassium.
Patients with dilutional hyponatremia are frequently drowsy, sometimes disorientated and occasionally pigmented. Their plasma sodium concentration can be restored to normal, with restoration of their mental state to normal, by the administration of fludrocortisone in a dose of 4 mg daily. Those with renal tubular defects require sodium and potassium supplements as well.
This complication occurs in oat cell carcinoma of the bronchus as well as in other non-neoplastic cerebral and lung diseases. Material with antidiuretic activity has been isolated from the tumour. Carcinoid Syndrome Serotonin (5-hydroxytryptamine) (5-HT) usually secreted by argentaffin tumours of the gastrointestinal tract, may also be secreted by adenomata and occasionally by oat cell carcinomata of the bronchus. This substance is normally destroyed in the liver and possibly lungs, but secondaries may appear in the liver, giving rise to a syndrome of episodic vivid flushing of the skin, diarrhea and bronchospasm. Right-sided valvular heart lesions may also appear. A variant has been described in which the tumour, histologically an oat cell carcinoma of the lung, secreted 5hydroxytryptophan (5-HTP) instead of 5-HT.
Hyperthyroidism
Both cancer and hyperthyroidism are common diseases and much more information is required before an association between the two can be considered as established. The largest series lists 34 collected cases. The neoplasms involved included those originating in the bronchus, gastrointestinal tract, prostate, embryonal carcinoma of the testis and chorioncarcinoma. There seems to be a particularly close association between trophoblastic tumours and hyperthyroidism. A substance having properties resembling those of thyroid-stimulating hormone has been found in the blood of 3 of these patients. High proteinbound iodine concentration was present in the plasma. The usual clinical manifestation is tachycardia. Eye signs and tremor were present in very few and none had a goitre.
Red Cell Aplasia Red cell aplasia, resulting in severe anemia, has been reported most commonly in association with thymoma, but has also been reported as a complication of carcinoma of the bronchus. The plasma contains a substance capable of depressing iron utilization in rabbits.
Neurological Complications
Cancer may of course produce neurological complications from cerebral metastases. On the other hand, neurological complications occur in patients with cancer which cannot be ascribed to secondaries. Peripheral neuritis and myopathy are the commonest manifestations; in a few cases the myopathy has myasthenic characteristics. Cerebellar atrophy may also occur. These neurological complications are most common in patients with carcinoma of the bronchus (16%), but have also been encountered in carcinoma of the breast (4%), uterus, ovary, stomach and prostate. No correlation has been noted between the size or site of the neoplasm and the degree of neurological involvement. The reported incidence of neurological complications depends, of course, on the thoroughness of the neurological examination.
Discussion
Frequency ofoccurrence ofmetabolic abnormality: It is difficult to assess the frequency of manifestations secondary to cancer. A survey of 100 consecutive admissions of patients with carcinoma of the bronchus to University College Hospital over a six-month period showed that 2 had dilutional hyponatrnmia, 2 hypokalkmic alkalosis and one severe myasthenic myopathy. Less severe neurological manifestations have been reported in up to 50% of cancer patients; the frequency of these neurological abnormalities obviously depends on the expertise of the examining physician. Such complications are present more commonly than is now believed because they are not looked for. Some of them are correctable and their correction may make the patient's remaining days more pleasant, although it may not add to their number. Aid to diagnosis: The neurological complications of cancer may develop two to three years before the manifestations of malignancy appear. One patient had severe myasthenic myopathy three years before she had a haemoptysis and carcinoma cells were found in her sputum. Unexplained myopathy or neuropathy should draw attention to the possibility of carcinoma, as should dilutional hyponatremia or hypokalemic alkalosis for which no cause is found. Effect on prognosis: It is agreed by those who have observed patients with the complication of bilateral adrenocortical hyperplasia that the cancer progresses more rapidly than is usual from the natural history of the disease. Hymans & Doe (1962) have made interesting observations on 51 unselected cases of carcinoma of the bronchus. A four-hour corticotrophin infusion was performed on these patients. The mean plasma concentration of 1 l-hydroxycorticoids at the end of the test was 55 ,ug/100 ml. Those with a response lower than this had a mean survival time of ninety-two days, whilst those with a response greater than this had a survival time of only twenty-three days. Those with an undifferentiated carcinoma of the bronchus had a higher initial plasma concentration and a brisker response than those with a differentiated carcinoma. Steroid studies can therefore be of prognostic value in these patients.
Patients with oat cell carcinoma of the bronchus and dilutional hyponatrnmia appear to survive longer than would be expected. Two patients had 'unresolved pneumonia' in the site where they ultimately developed a visible carcinoma two and two and a half years before death. The presumption is that they had carcinoma all the time.
Cause of metabolic abnormalities: The cause of some, at least, of these metabolic abnormalities is the production of physiologically active polypeptides by the tumour. Corticotrophin, antidiuretic hormone, parathormone, thyroid-stimulating hormone and gonadotrophin have been identified by biological or immunological methods. In the case of carcinoma of the bronchus these complications are produced solely by those of oat cell type, i.e. by the most undifferentiated tumours.
All undifferentiated cells initially are totipotent; as development proceeds, cells become more and more specialized as genetic informnation for reproduction of proteins is suppressed. Cancer cells may represent cells that have escaped from repression. Alternatively, the polypeptides may represent fragments of proteins thrown off during uncontrolled protein synthesis in tumour cells which by chance have biological activity. In view of the possible influence of these polypeptides on prognosis, study of the effects of these polypeptides on the rate of progression of cancer may throw some light on the factors influencing tumour growth. Acknowledgments: I am grateful to Dr E W Emery and Dr J N Godlee, radiotherapists, as well as to the physicians and surgeons of University College Hospital who have given me access to patients with carcinoma of the bronchus. The work is supported by the British Empire Cancer Campaign.
